Immune-inflammatory mechanisms in IFNγ-mediated anti-tumor activity
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 10 (2) , 113-123
- https://doi.org/10.1006/scbi.2000.0314
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functionsOncogene, 1998
- Lymphocytes, cytokines, inflammation, and immune traffickingCurrent Opinion in Rheumatology, 1996
- IL-12 Gene Therapy Using Direct Injection of Tumors with Genetically Engineered Autologous Fibroblasts. University of Pittsburgh, Pittsburgh, PennsylvaniaHuman Gene Therapy, 1995
- Microvascular expression of mala‐2 correlates with In vivo lymphocyte trafficking and is preferentially enhanced in tumors by tumor necrosis factor‐α and interleukin‐1αInternational Journal of Cancer, 1994
- Antitumor Activity of Interleukin-12Clinical Immunology and Immunopathology, 1994
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?Immunology Today, 1994
- Which steps in lymphocyte recirculation are regulated by interferon-γ?Research in Immunology, 1994
- Protective Activity of Recombinant Murine Tumor Necrosis Factor-α and Interferon-γ Against Experimental Murine Lung Carcinoma MetastasesJournal of Interferon Research, 1990
- The anti‐tumor effect of recombinant interferon alpha or gamma is influenced by tumor locationInternational Journal of Cancer, 1987
- Comparative Antiproliferative Efficacies of Human and InterferonsJournal of General Virology, 1983